Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 394.00 | 283.25 | 1.3910 | 1.2685 | |
| MCF 10A | Linsitinib | 0.01 | uM | 9 | 156.25 | 46.09 | 482.00 | 283.25 | 1.7017 | 1.4500 |
| MCF 10A | 17-AAG | 0.1 | uM | 9 | 156.25 | 46.09 | 52.00 | 283.25 | 0.1836 | 0.0471 |
| MCF 10A | Lapatinib | 0.01 | uM | 9 | 156.25 | 46.09 | 200.00 | 283.25 | 0.7061 | 0.7512 |
| MCF 10A | Lapatinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 236.00 | 283.25 | 0.8332 | 0.8654 |
| MCF 10A | 17-AAG | 0.31623 | uM | 9 | 156.25 | 46.09 | 43.00 | 283.25 | 0.1518 | -0.0262 |
| MCF 10A | Erlotinib | 0.1 | uM | 9 | 156.25 | 46.09 | 137.00 | 283.25 | 0.4837 | 0.5157 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 225.00 | 283.25 | 0.7944 | 0.8317 | |
| MCF 10A | Erlotinib | 19.9526 | uM | 9 | 156.25 | 46.09 | 41.00 | 283.25 | 0.1448 | -0.0437 |
| MCF 10A | Lapatinib | 0.031623 | uM | 9 | 156.25 | 46.09 | 305.00 | 283.25 | 1.0768 | 1.0573 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 46.09 | 243.00 | 283.25 | 0.8579 | 0.8863 |
| MCF 10A | 17-AAG | 0.031623 | uM | 9 | 156.25 | 46.09 | 35.00 | 283.25 | 0.1236 | -0.0998 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 251.00 | 283.25 | 0.8861 | 0.9098 | |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 884.00 | 835.25 | 1.0584 | 1.0367 | |
| MCF 10A | Erlotinib | 0.01 | uM | 9 | 312.50 | 96.23 | 1166.00 | 835.25 | 1.3960 | 1.2259 |
| MCF 10A | 17-AAG | 0.000302 | uM | 9 | 312.50 | 96.23 | 938.00 | 835.25 | 1.1230 | 1.0758 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 312.50 | 96.23 | 659.00 | 835.25 | 0.7890 | 0.8536 |
| MCF 10A | Erlotinib | 1 | uM | 9 | 312.50 | 96.23 | 142.00 | 835.25 | 0.1700 | 0.1329 |
| MCF 10A | Lapatinib | 10 | uM | 9 | 312.50 | 96.23 | 88.00 | 835.25 | 0.1054 | -0.0283 |
| MCF 10A | Linsitinib | 0.031623 | uM | 9 | 312.50 | 96.23 | 1327.00 | 835.25 | 1.5887 | 1.3202 |
| MCF 10A | 17-AAG | 0.0001 | uM | 9 | 312.50 | 96.23 | 1623.00 | 835.25 | 1.9431 | 1.4750 |
| MCF 10A | Erlotinib | 0.031623 | uM | 9 | 312.50 | 96.23 | 1233.00 | 835.25 | 1.4762 | 1.2661 |
| MCF 10A | Lapatinib | 1 | uM | 9 | 312.50 | 96.23 | 1313.00 | 835.25 | 1.5720 | 1.3123 |
| MCF 10A | Linsitinib | 10 | uM | 9 | 312.50 | 96.23 | 366.00 | 835.25 | 0.4382 | 0.5350 |
| MCF 10A | Erlotinib | 3.1623 | uM | 9 | 312.50 | 96.23 | 152.00 | 835.25 | 0.1820 | 0.1579 |